BIOA — Bioiasis AD Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.662 | 0.547 | 0.583 | 0.062 | 0.061 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.033 | 0.03 | 0.025 | 5.12 | 8.5 |
Prepaid Expenses | |||||
Total Current Assets | 0.695 | 0.579 | 0.608 | 6.31 | 11.6 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.695 | 0.581 | 0.608 | 15.3 | 20.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.058 | 0.022 | 0.036 | 5.48 | 10.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 0.058 | 0.022 | 0.042 | 15.2 | 20.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 0.637 | 0.559 | 0.566 | 0.109 | 0.255 |
Total Liabilities & Shareholders' Equity | 0.695 | 0.581 | 0.608 | 15.3 | 20.6 |
Total Common Shares Outstanding |